Learn About Neuropathy Clinical Trials Near You

Understanding Neuropathy and Why Clinical Trials Matter

Neuropathy refers to damage or disease affecting one or more peripheral nerves. These are the nerves that connect your brain and spinal cord to the rest of your body. When nerves become damaged, they send incorrect signals or stop sending signals altogether, leading to weakness, numbness, or pain—typically in the hands and feet. According to the National Institute of Neurological Disorders and Stroke, peripheral neuropathy affects approximately 20 million people in the United States.

There are many types of neuropathy. Diabetic neuropathy is the most common type, affecting up to 50% of people with diabetes. Other causes include infections, injuries, toxin exposure, inherited conditions, and autoimmune diseases. Some people develop neuropathy from chemotherapy treatments used in cancer care. In some cases, doctors cannot identify a specific cause, which is called idiopathic neuropathy.

Clinical trials are research studies that test new treatments, therapies, or diagnostic approaches in human participants. For neuropathy, trials might investigate new medications, physical rehabilitation techniques, medical devices, or combination treatments. Participating in a clinical trial allows people to potentially access new treatments before they become widely available, while also contributing to medical knowledge that may help others in the future.

Why do clinical trials matter for neuropathy? Currently available treatments often manage symptoms rather than reverse nerve damage. Many people find that standard treatments—like over-the-counter pain relievers or older medications—provide only partial relief. Clinical trials investigate whether newer approaches can provide better outcomes, fewer side effects, or address underlying causes of nerve damage.

Practical takeaway: Understanding that neuropathy is a treatable condition with ongoing research helps you recognize why exploring clinical trial options may be worth investigating further. Learning about new treatment approaches gives you information to discuss with your healthcare provider.

Types of Neuropathy Clinical Trials Currently Underway

Clinical trials for neuropathy fall into several categories based on what they test. Drug trials investigate pharmaceutical interventions—either new medications or new uses for existing drugs. For example, some trials test medications that may reduce inflammation affecting nerves, while others examine drugs that might promote nerve regeneration. These trials typically involve taking a pill or injection on a schedule while researchers monitor your symptoms and health.

Device-based trials test medical equipment or technology. This might include electrical stimulation devices that send signals to affected nerves, advanced monitoring equipment that tracks nerve function, or wearable devices that provide support or feedback. Some device trials combine technology with other treatments, such as using electrical stimulation alongside physical therapy.

Behavioral and rehabilitative trials focus on physical therapy, exercise programs, occupational therapy, or pain management techniques. These might test new rehabilitation approaches, different exercise intensities, or novel pain management strategies. Some trials examine whether specific types of movement or activity can slow neuropathy progression or improve function.

Combination therapy trials test whether using multiple treatments together produces better results than single treatments. For instance, a trial might combine a new medication with physical therapy, or test a device alongside behavioral intervention.

Gene therapy and cellular therapy trials represent cutting-edge approaches. These studies investigate whether modifying genetic material or using specific cell types can repair nerve damage. While these trials are less common than drug trials, they represent significant research directions for severe neuropathy cases.

The ClinicalTrials.gov database, maintained by the National Library of Medicine, currently lists thousands of neuropathy-related studies. Some focus on specific neuropathy types (such as diabetic neuropathy or chemotherapy-related neuropathy), while others investigate treatments for general peripheral neuropathy.

Practical takeaway: Different trial types test different approaches. Knowing the basic categories helps you understand what participating in a particular trial would involve and whether that type of research aligns with your interests.

How to Search for Neuropathy Clinical Trials Near You

The primary resource for finding clinical trials is ClinicalTrials.gov, a free searchable database of thousands of studies. To search for neuropathy trials, you can visit the website and enter "neuropathy" or a specific type like "diabetic neuropathy" or "peripheral neuropathy" in the condition search field. You can then filter results by location—entering your state, city, or zip code to find studies near you.

The search results show the trial name, sponsoring organization, trial phase, study status (recruiting, active but not recruiting, or closed), and the trial location. Each trial has a detailed page explaining the purpose, what participation involves, locations where you can participate, and contact information for the research team.

Beyond ClinicalTrials.gov, some trials are listed through medical centers and universities. Major research hospitals often have clinical trial coordinators who can discuss studies related to neuropathy. Calling your local hospital's research department or asking your neurologist about ongoing studies they know about represents another search method.

Patient advocacy organizations focused on neuropathy sometimes maintain lists of trials or can provide information about research opportunities. Organizations like the Neuropathy Action Foundation or the Foundation for Peripheral Neuropathy track studies and may have resources on their websites.

When searching, you may encounter trials in different phases. Phase 1 trials test safety in a small group (20-100 people). Phase 2 trials examine effectiveness in larger groups (100-500 people). Phase 3 trials compare the new treatment to standard care in even larger populations (1,000-5,000 people). Phase 4 trials continue monitoring treatments after approval. Most neuropathy trials available to participants are Phase 2 or Phase 3 studies.

Some important search tips: Note the trial status. Recruiting trials are actively enrolling participants. Active trials that are not recruiting have enough participants but may welcome future enrollment. Check the distance—some trials require frequent visits while others allow remote participation or occasional travel. Review the eligibility criteria section to understand basic requirements before contacting the research team.

Practical takeaway: ClinicalTrials.gov is your starting point, but combining it with direct outreach to local medical institutions gives you the most complete picture of trials available in your area.

Understanding Trial Requirements and What Participation Involves

Clinical trials have inclusion and exclusion criteria that define who may participate. Inclusion criteria describe characteristics you should have to join—for example, being at least 18 years old, having diagnosed neuropathy for at least 6 months, or having a specific type of neuropathy. Exclusion criteria describe situations that would prevent participation—such as being pregnant, having certain other medical conditions, or taking medications that might interfere with the study.

Most neuropathy trials require an initial screening visit where the research team explains the study and performs basic assessments. This might include blood work, nerve function tests (like electromyography or nerve conduction studies), or imaging studies. This helps researchers confirm you have the condition being studied and assess your baseline health status.

The actual participation schedule varies widely. Some trials require weekly visits for several months. Others require monthly visits over a year or longer. Some combination trials may require visits every two weeks. Remote components are increasingly common—some trials use virtual visits or home-based assessments to reduce burden on participants.

What happens during visits depends on the trial type. Drug trials typically involve receiving medication and answering questions about symptoms and side effects. Device trials might involve wearing equipment, having devices adjusted, or performing tests with the device. Behavioral trials usually involve therapy sessions or guided exercise. Many trials combine multiple components—for example, a drug plus physical therapy.

Duration varies significantly. Some trials last 12 weeks while others continue for two years or longer. It's important to understand the full time commitment before enrolling. Some trials also require lifestyle modifications, such as avoiding certain foods, maintaining an exercise schedule, or limiting alcohol consumption.

Most trials cover costs related to participation—such as study medication, required visits, and tests performed as part of the research. However, payment structures vary. Some trials provide compensation for your time (typically $20-$100 per visit depending on the study). Others provide only parking reimbursement or free treatment. Clarifying cost and compensation details before enrolling helps you make an informed decision.

Practical takeaway: Before contacting a trial, review the eligibility criteria and estimated time commitment. This prevents wasting time pursuing trials you wouldn't be able to join and helps you identify studies that fit your schedule and health situation.

The Consent Process and Your Rights